Prognostic value of hematological and inflammation marker in acute coronary syndrome
Guardado en:
Autores principales: | Tejinder Singh Malhi, Yash Paul Sharma, Kunaal Makkar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f183354f365145d2ba4ecfd5f0b4cf30 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Use of nonconventional biomarkers in acute coronary syndrome in COVID-19 pandemic
por: Kunaal Makkar, et al.
Publicado: (2021) -
Usefulness of calcium and phosphorus metabolism biomarkers in predicting outcome in acute coronary syndrome
por: Tejinder Singh Malhi, et al.
Publicado: (2021) -
Association between admission lactate levels and mortality in patients with acute coronary syndrome admitted in cardiac care unit in tertiary care unit
por: Tejinder Singh Malhi, et al.
Publicado: (2021) -
Observational study in a tertiary care center in North India comparing demographic profile and outcome in patients with COVID-19 ACS and non COVID-19 ACS
por: Kunaal Makkar, et al.
Publicado: (2021) -
Cardiogenic shock complicating acute myocardial infarction in COVID pandemic – Clinical characteristics, management and outcomes
por: Yash Paul Sharma, et al.
Publicado: (2021)